196 related articles for article (PubMed ID: 30122018)
1. [Prognostic significance of miRNA-223 targeting SOX11 in mantle cell lymphoma].
Zhang Q; Zhang WT; Wu SS; Yuan JJ; Tian L; Liu YY; Zuo WL; Song YP; Zhou KS
Zhonghua Xue Ye Xue Za Zhi; 2018 Jul; 39(7):579-583. PubMed ID: 30122018
[No Abstract] [Full Text] [Related]
2. miR-223 is repressed and correlates with inferior clinical features in mantle cell lymphoma through targeting SOX11.
Zhou K; Feng X; Wang Y; Liu Y; Tian L; Zuo W; Yi S; Wei X; Song Y; Qiu L
Exp Hematol; 2018 Feb; 58():27-34.e1. PubMed ID: 29158064
[TBL] [Abstract][Full Text] [Related]
3. [Expression of SOX11 mRNA in mantle cell lymphoma and its clinical significance].
Wang YY; Yu Z; Yi SH; Li ZJ; Li CH; Xie ZQ; Li F; Zang MR; Hao M; Qiu LG
Zhonghua Xue Ye Xue Za Zhi; 2012 Jul; 33(7):556-60. PubMed ID: 22967417
[TBL] [Abstract][Full Text] [Related]
4. Elevated SOX11 mRNA level correlates with favorable prognosis in mantle cell lymphoma.
He J; Xi Y; Gao N; Xu E; Xie L; Chang J; Liu J
J BUON; 2019; 24(4):1679-1685. PubMed ID: 31646825
[TBL] [Abstract][Full Text] [Related]
5. MiR-132-3p serves as a tumor suppressor in mantle cell lymphoma via directly targeting SOX11.
Wu B; Li J; Wang H; Wu Q; Liu H
Naunyn Schmiedebergs Arch Pharmacol; 2020 Nov; 393(11):2197-2208. PubMed ID: 32040593
[TBL] [Abstract][Full Text] [Related]
6. [Relationship of Expression Between SOX11 and PAX5 in Pathological Tissue Specimens of Patients with Mantle Cell Lymphoma and Its Clinical Significance].
Jing CX; Feng Y; Cao X; Xu CG
Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 May; 51(3):355-360. PubMed ID: 32543142
[TBL] [Abstract][Full Text] [Related]
7. Association of SOX11 gene expression withclinical features and prognosis of mantle cell lymphoma.
He JX; Xi YF; Su LP; Gao N; Xu EW; Xie LW; Wang LY; Zheng YP; Han WE; Chang J; Wang HW
Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2556-2563. PubMed ID: 29771407
[TBL] [Abstract][Full Text] [Related]
8. Identification of miRNA-34a and miRNA-155 as prognostic markers for mantle cell lymphoma.
He J; Xi Y; Gao N; Xu E; Chang J; Liu J
J Int Med Res; 2021 May; 49(5):3000605211016390. PubMed ID: 34024195
[TBL] [Abstract][Full Text] [Related]
9. SOX11-negative Mantle Cell Lymphoma: Clinicopathologic and Prognostic Features of 75 Patients.
Xu J; Wang L; Li J; Saksena A; Wang SA; Shen J; Hu Z; Lin P; Tang G; Yin CC; Wang M; Medeiros LJ; Li S
Am J Surg Pathol; 2019 May; 43(5):710-716. PubMed ID: 30768440
[TBL] [Abstract][Full Text] [Related]
10. SOXC transcription factors in mantle cell lymphoma: the role of promoter methylation in SOX11 expression.
Wasik AM; Lord M; Wang X; Zong F; Andersson P; Kimby E; Christensson B; Karimi M; Sander B
Sci Rep; 2013; 3():1400. PubMed ID: 23466598
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-506 inhibits the proliferation and invasion of mantle cell lymphoma cells by targeting B7H3.
Zhu XW; Wang J; Zhu MX; Wang YF; Yang SY; Ke XY
Biochem Biophys Res Commun; 2019 Jan; 508(4):1067-1073. PubMed ID: 30553455
[TBL] [Abstract][Full Text] [Related]
12. SOX11 regulates the pro-apoptosis signal pathway and predicts a favorable prognosis of mantle cell lymphoma.
Yang W; Wang Y; Yu Z; Li Z; An G; Liu W; Lv R; Ma L; Yi S; Qiu L
Int J Hematol; 2017 Aug; 106(2):212-220. PubMed ID: 28429312
[TBL] [Abstract][Full Text] [Related]
13. Gene expression profiling and chromatin immunoprecipitation identify DBN1, SETMAR and HIG2 as direct targets of SOX11 in mantle cell lymphoma.
Wang X; Björklund S; Wasik AM; Grandien A; Andersson P; Kimby E; Dahlman-Wright K; Zhao C; Christensson B; Sander B
PLoS One; 2010 Nov; 5(11):e14085. PubMed ID: 21124928
[TBL] [Abstract][Full Text] [Related]
14. A highly sensitive and specific qPCR assay for quantification of the biomarker SOX11 in mantle cell lymphoma.
Hamborg KH; Bentzen HH; Grubach L; Hokland P; Nyvold CG
Eur J Haematol; 2012 Nov; 89(5):385-94. PubMed ID: 22827557
[TBL] [Abstract][Full Text] [Related]
15. Influence of MicroRNA-141 on Inhibition of the Proliferation of Bone Marrow Mesenchymal Stem Cells in Steroid-Induced Osteonecrosis via SOX11.
Meng CY; Xue F; Zhao ZQ; Hao T; Guo SB; Feng W
Orthop Surg; 2020 Feb; 12(1):277-285. PubMed ID: 31916393
[TBL] [Abstract][Full Text] [Related]
16. [Expression of myocyte enhancer factor 2B in mantle cell lymphoma and its clinical significance].
Liu F; Liu Q; Guo N; Zhang GM; Deng YF; Hu WW; Rao HL
Zhonghua Bing Li Xue Za Zhi; 2020 Jan; 49(1):40-46. PubMed ID: 31914533
[No Abstract] [Full Text] [Related]
17. Increased tumour angiogenesis in SOX11-positive mantle cell lymphoma.
Petrakis G; Veloza L; Clot G; Gine E; Gonzalez-Farre B; Navarro A; Bea S; Martínez A; Lopez-Guillermo A; Amador V; Ribera-Cortada I; Campo E
Histopathology; 2019 Nov; 75(5):704-714. PubMed ID: 31173643
[TBL] [Abstract][Full Text] [Related]
18. [Expression of MiR101 and EZH2 in Patients with Mantle Cell Lymphoma and Its Clinical Significance].
Lin YL; Zou ZK; Su HY; Huang YQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Jun; 27(3):820-826. PubMed ID: 31204938
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of p53, Sox11, and Pax5 co-expression in mantle cell lymphoma.
Jing C; Zheng Y; Feng Y; Cao X; Xu C
Sci Rep; 2021 Jun; 11(1):11896. PubMed ID: 34099776
[TBL] [Abstract][Full Text] [Related]
20. Identification of V-ATPase as a molecular sensor of SOX11-levels and potential therapeutic target for mantle cell lymphoma.
Emruli VK; Olsson R; Ek F; Ek S
BMC Cancer; 2016 Jul; 16():493. PubMed ID: 27430213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
